GB/T 16886.12-2017
Biological evaluation of medical devices—Part 12:Sample preparation and reference materials (English Version)
- Standard No.
- GB/T 16886.12-2017
- Language
- Chinese, Available in English version
- Release Date
- 2017
- Published By
- 中华人民共和国国家质量监督检验检疫总局、中国国家标准化管理委员会
- Status
- 2024-12
- Replace By
- GB/T 16886.12-2023
- Latest
- GB/T 16886.12-2023
- Replace
- GB/T 16886.12-2005
GB/T 16886.12-2017 Referenced Document
- ISO 14971 Medical devices - Application of risk management to medical devices*， 2019-12-01 Update
GB/T 16886.12-2017 history
- 2023 GB/T 16886.12-2023 Biological Evaluation of Medical Devices Part 12: Sample Preparation and Reference Materials
- 2017 GB/T 16886.12-2017 Biological evaluation of medical devices—Part 12:Sample preparation and reference materials
- 2005 GB/T 16886.12-2005 Biological evaluation of medical devices-Part 12:Sample preparation and reference materials
- 2000 GB/T 16886.12-2000 Biological evaluation of medical devices--Part 12: Sample preparation and reference materials
GB/T 16886.12-2017 -All Parts
GB/T 16886.1-2022 Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process
GB/T 16886.10-2017 Biological evaluation of medical devices—Part 10: Tests for irritation and skin sensitization
GB/T 16886.11-2021 Biological evaluation of medical devices—Part 11: Tests for systemic toxicity
GB/T 16886.12-2023 Biological Evaluation of Medical Devices Part 12: Sample Preparation and Reference Materials
GB/T 16886.13-2017 Biological evaluation of medical devices—Part 13: Identification and quantification of degradation products from polymeric medical devices
GB/T 16886.14-2003 Biological evaluation of medical devices--Part 14: Identification and quantification of degradation products from ceramics
GB/T 16886.15-2022 Biological evaluation of medical devices—Part 15: Identification and quantification of degradation products from metals and alloys
GB/T 16886.16-2021 Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables
GB/T 16886.17-2005 Biological evaluation of medical devices.Part 17:Establishment of allowable limits for leachable substances
GB/T 16886.18-2022 Biological evaluation of medical devices—Part 18: Chemical characterization of medical device materials within a risk management process
GB/T 16886.19-2022 Biological evaluation of medical devices—Part 19: Physico-chemical, morphological and topographical characterization of materials
GB/T 16886.2-2011 Biological evaluation of medical devices.Part 2: Animal welfare requirements
GB/T 16886.20-2015 Biological evaluation of medical devices.Part 20:Principles and methods for immunotoxicology testing of medical devices
GB/T 16886.23-2023 Biological Evaluation of Medical Devices Part 23: Stimulation Test
GB/T 16886.3-2019 Biological evaluation of medical devices—Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
GB/T 16886.4-2022 Biological evaluation of medical devices—Part 4: Selection of tests for interactions with blood
GB/T 16886.5-2017 Biological Evaluation of Medical Devices Part 5: In Vitro Cytotoxicity Tests
GB/T 16886.6-2022 Biological evaluation of medical devices—Part 6:Tests for local effects after implantation
GB/T 16886.7-2015 Biological evaluation of medical devices—Part 7: Ethylene oxide sterilization residuals
GB/T 16886.9-2022 Biological Evaluation of Medical Devices Part 9: Qualitative and Quantitative Framework for Potential Degradation Products